Optimization of the proportions of advantageous components in the hypolipidemic “bioequivalent substance system” of Jiang-Zhi-Ning and its mechanism of action

Author:

Li Yumiao1,Zhang Yan1,Zhang Yu1,Lin Tianfeng1,Gao Yanyan1,Cai Yuan1,Zhou Chang1,Yang Leyi1,Liu Bin12,Dong Shifen1,Jiang Yanyan12ORCID

Affiliation:

1. School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China

2. The Key Research Laboratory of "Exploring Effective Substance in Classic and Famous Prescriptions of Traditional Chinese Medicine". The State Administration of Traditional Chinese Medicine of the People’s Republic of China, Beijing, China

Funder

Beijing Municipal Natural Science Foundation

Publisher

Informa UK Limited

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine

Reference40 articles.

1. Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment

2. [Effect of dose compatibility of main chemical components from Astragali Radix-Angelicae Sinensis Radix on proliferation of VSMCs based on uniform design];Chen LB;Chin J Exp Tradit Med Form,2023

3. The Effects of Jiang-Zhi-Ning and Its Main Components on Cholesterol Metabolism

4. Lipid-lowering and antioxidant activities of Jiang-Zhi-Ning in Traditional Chinese Medicine

5. Chinese Pharmacopoeia Commission. 2020. Pharmacopoeia of the People’s Republic of China (Vol I). Beijing: China Medical Science Press.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3